Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Vaccinations01:51

Vaccinations

Overview
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of kappa- and mu-opioid receptor agonists on Ca2+ channels in neuroblastoma cells: involvement of the orphan opioid receptor.

European journal of pharmacology·1999
Same author

Mutational analysis of the putative fusion domain of Ebola virus glycoprotein.

Journal of virology·1999
Same author

Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.

Antimicrobial agents and chemotherapy·1999
Same author

Hyperenhancing focal liver lesions: differential diagnosis with helical CT.

AJR. American journal of roentgenology·1999
Same author

Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.

International journal of pharmaceutics·1999
Same author

Post-weaning multisystemic wasting syndrome in Spain.

The Veterinary record·1999

Related Experiment Video

Updated: May 12, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

Immunization for Ebola virus infection

L Xu1, A Sanchez, Z Yang

  • 1Department of Biological Chemistry, University of Michigan Medical Center, Ann Arbor 48109-0650, USA.

Nature Medicine
|January 14, 1998
PubMed
Summary

Genetic vaccination using plasmids encoding Ebola virus proteins successfully protected guinea pigs against lethal infection. This approach, targeting viral nucleoprotein (NP) and glycoprotein (GP), offers a promising strategy for developing Ebola virus immunity and controlling disease spread.

More Related Videos

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

Related Experiment Videos

Last Updated: May 12, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

Area of Science:

  • Virology
  • Immunology
  • Vaccine Development

Background:

  • Ebola virus infection is a severe, often fatal disease characterized by fever, hemorrhage, and hypotension.
  • Previous efforts to induce protective immunity against Ebola virus have been unsuccessful.

Purpose of the Study:

  • To investigate the efficacy of genetic vaccination using plasmids encoding Ebola virus proteins in conferring protection against lethal infection.
  • To analyze the immune responses, including antibody titers and T-cell responses, to specific viral proteins (NP, sGP, GP).

Main Methods:

  • Immunization of guinea pigs with plasmids encoding Ebola virus nucleoprotein (NP) and glycoprotein (sGP or GP).
  • Assessment of protection against lethal Ebola virus challenge in a guinea pig model.
  • Analysis of antibody titers and antigen-specific T-cell responses to viral proteins.

Main Results:

  • Genetic vaccination with plasmids encoding viral proteins achieved protection against the lethal effects of Ebola virus infection in a guinea pig model.
  • Protection correlated with the development of antibody titers and antigen-specific T-cell responses to the secreted or transmembrane forms of the glycoprotein (sGP or GP).

Conclusions:

  • Genetic vaccination represents a viable strategy for developing protective immunity against Ebola virus.
  • This approach may contribute to efforts aimed at limiting the spread of Ebola virus disease.